Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs ropivacaine for fascia iliaca block in ERAS hip fracture surgery
ChiCTR2500104528Phase 4Completed
- Sponsor
- Guiyang Second People's Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of bupivacaine in hip fracture (2 arms), sponsored by Guiyang Second People's Hospital. Primary endpoints: Postoperative pain at rest and during movement, Degree of motor block and 2 more. Started Jun 2025; status: completed.
02
Drugs
bupivacaine
03
Conditions
hip fracture
Beyond the preview
Go deeper on ChiCTR2500104528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104528.